Embed this press release by copying the code below:
Frontida BioPharm, Inc. Launches CAT.one Testing to Support Abuse-Deterrent Product Development
Frontida BioPharm, Inc. Launches CAT.one Testing to Support Abuse-Deterrent Product Development